Pune: Serum Institute of India (SII), on Sunday, issued a clarification that the current claims over commercialising COVISHIELD’s availability in 73 days, in the media is completely false and conjectural.
The official handle of the institute took to Twitter to issue the clarification.
“Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use. COVISHIELD will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place,” said the notice by SII.
“The phase-3 trials for the Oxford-AstraZeneca vaccine, are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially.”
New Delhi: India has taken the first step in its attempt to host the 2036…
Bhadrak: Amid allegations that bullets were fired at the Nandan Kanan Express train near Charampa…
Bhubaneswar: Odisha Vigilance on Tuesday arrested senior assistant in Additional District Public Health Office (Family…
Bhubaneswar: The regional centre of India Meteorological Department (IMD) has sounded yellow warning for four…
Bhubaneswar: Odisha’s Deputy Chief Minister Pravati Parida held a meeting with the Indian High Commissioner…
Bhubaneswar: Chief Minister Mohan Charan Majhi on Tuesday informed about the central government's plans for…
Bhubaneswar: Amid a brouhaha over cracks detected on the ‘Meghanada Pacheri’ surrounding Shree Jatannath Temple…
New Delhi: In a recently released guidelines, the Department of Pension and Pensioners’ Welfare (DoPPW)…